Organization
Regeneron Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Regeneron Pharmaceuticals, Inc.
... research to the investment community. Today we are offering reports on RARE, REGN, SGEN, and SGMO which can be accessed for free by signing up ...
... Regeneron Pharmaceuticals has formed a pre-competitive consortium with AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen ...
... SAN FRANCISCO—Sanofi and Regeneron may have had a hot start in 2017 with Dupixent, approved in ...
... among 300 high school seniors nationwide named scholars Tuesday in the prestigious Regeneron Science Talent Search, the country's oldest high school competition in the math ...
... Older, simpler versions of safe harbor statements also got a good reception. Regeneron Pharmaceuticals CEO Leonard Schleifer led off his presentation with a disclaimer from ...
... some of the world’s largest pharmaceutical companies are pooling resources to fund Regeneron Pharmaceuticals ambitious genetic and medical database aimed at bolstering the search for ...
... Biogen Inc. and Pfizer Inc. will pay $10 million each to Regeneron Pharmaceuticals Inc., which began the project last year in partnership with the U.K. ...
... $30 billion deal for Actelion’s stable of marketed drugs. Tuesday, 7:32 a.m.: Regeneron CEO Len Schleifer humorously reminisced Monday about the company’s beginnings in 1988. ...
... pharma and healthcare marketing challenges. Featured Speakers: Natalie Mancuso,Senior Product Manager, Marketing, REGENERON Anthony Molloy, Esq.,Vice President, Legal and Compliance, Deputy General Counsel, PACIRA PHARMACEUTICALS ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), along with new collaborators AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen and ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs - ...
... Porges wrote that of companies in his team's coverage, Biogen, AbbVie and Regeneron are set to gain the most from the tax bill. Biogen and ...
... Hoffmann-La Roche AG, Glaxosmithkline plc., Medimmune (Astrazeneca), Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Valeant Pharmaceuticals Inc. and other. Key Topics Covered: Chapter ...
... development," Cobb said. In late November, Decibel entered into a partnership with Regeneron, a biotech drug developer in Tarrytown, New York. Besides accessing Regeneron's robust ...
... area before leasing space on UAlbany's Health Sciences Campus where drug developer Regeneron Pharmaceuticals and the Pharmaceutical Research Institute are located. The company signed a ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 36th Annual J.P. Morgan ...
... the United States Court of Appeals for the Federal Circuit denied Regeneron Pharmaceutical Inc.'s ("Regeneron") request for a rehearing en banc to reconsider its decision ...
... 2017, -- ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a clinical collaboration to advance ISA101, an immunotherapy ...
... Regeneron and Sanofi’s PD-1 candidate cemiplimab will be tested alongside a human papillomavirus ...
... company in the region pretty soon. What's happening across the river at Regeneron, the pharmaceutical company. I think advanced manufacturing is a place where we ...
... TARRYTOWN, N.Y. and PARIS - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive topline results from a pivotal ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced updates related to its collaboration programs with Sanofi, ...
... Regeneron Pharmaceuticals, Inc.(NASDAQ:REGN) andSanofitoday announced positive topline results from a pivotal Phase 2 clinical ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous ...
... be way back in the race for market share, but Sanofi and Regeneron touted new topline data for their midstage checkpoint inhibitor in a certain ...
Want to see the full history on Regeneron Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial